

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.27%
+0.61%
+3.26%
-10.82%
-8.09%
ZTS
Zoetis
$146.59
Strengths

Earnings are forecast to grow

Pays a reliable dividend
Risk Analysis

Trading above its fair value
Chart
$143.49 (+2.16%)
$147.91 (-0.89%)
$170.3 (-13.92%)
$170.37 (-13.96%)
ZTS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

ZTS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend
Future
Future

Earnings are forecast to grow

Trading above its fair value
![]()
ZTS Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ZTS Street view is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayZTS Earnings
The TTM reflects 12-month period, providing review of ZTS financial performance.
The company financial health has moderately improved over the past year
Financial Score
What is ZTS current stock price?
What are ZTS stock strengths?
What risks are associated with ZTS stock?
When is ZTS next earnings report?
What is ZTS market cap and volume?
What is ZTS's current Stock IQ?
Should I buy ZTS stock right now?
Is ZTS a Strong Buy right now?
What does a 'Strong Buy' rating mean for ZTS?
What does a 'Strong Sell' rating mean for ZTS?
What factors influence ZTS's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+1.27%
+0.61%
+3.26%
-10.82%
-8.09%
ZTS
Zoetis
Current Price
$146.59
Stock Insights
Strengths

Earnings are forecast to grow

Pays a reliable dividend
Risk Analysis

Trading above its fair value
Chart
$143.49 (+2.16%)
$147.91 (-0.89%)
$170.3 (-13.92%)
$170.37 (-13.96%)
ZTS Analysts Opinion
ZTS Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Pays a reliable dividend
Future
Future

Earnings are forecast to grow

Trading above its fair value
![]()
ZTS Analysts opinion is positive but there was a setback from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ZTS Street view is extremely bullish and have positive views on the near-term outlook
ZTS has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Average key support and resistance price levels.
ZTS Earnings
The TTM data reflects the most recent 12-month period, providing overview of ZTS financial performance.
ZTS Financial Health
The company financial health has moderately improved over the past year
Financial Score
ZTS Latest Analysis
UBS Maintains Zoetis (ZTS) Neutral Recommendation. Fintel reports that on October 20 2025 UBS maintained coverage of Zoetis (NYSE:ZTS) with a Neutral recommendation. Analyst Price Forecast Suggests 34.73% Upside
Tue Oct 21, 2025
Zoetis Stock: Outlook Remains Muted. Zoetis Inc. (NYSE:ZTS) is currently in its final 18th phase of the Adhishthana cycle on the weekly charts. Having formed a poor triad structure the stock'.s outlook doesn'.t look encouraging. With UBS recently lowering its price targets it adds further weight to the view that Zoetis could stay stuck in a slump through June 2026. In the Adhishthana framework the behavior of Phase 18 is largely determined by Phases 14 15 and 16 collectively known as the
Tue Oct 21, 2025
Valideas Top Health Care Stocks Based On Martin Zweig - 10/20/2025. The following are the top rated Health Care stocks according to Valideas Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth reasonable valuations and low debt.ZOETIS
Mon Oct 20, 2025
Valideas Top Health Care Stocks Based On Martin Zweig - 10/15/2025. The following are the top rated Health Care stocks according to Valideas Growth Investor model based on the published strategy of Martin Zweig. This strategy looks for growth stocks with persistent accelerating earnings and sales growth reasonable valuations and low debt.ZOETIS
Wed Oct 15, 2025
Zoetis Gets Health Canada Approval For Lenivia To Treat Osteoarthritis Pain In Dogs . (RTTNews) - Zoetis Inc. (ZTS) on Wednesday announced that Health Canada has approved Lenivia for the alleviation of pain associated with osteoarthritis (OA) in dogs.
Wed Oct 15, 2025
Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again. Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Tue Oct 14, 2025
Zoetis Gains CVMP Backing for Lenivia Eyes EU Approval in Dog OA Pain . ZTS secures CVMPs positive opinion recommending the approval of Lenivia a long-acting OA pain therapy for dogs with the final decision expected in late 2025.
Mon Oct 13, 2025
Zoetis gains EMA panel endorsement for Lenivia for osteoarthritis pain in dogs.
Fri Oct 10, 2025
Zoetis declares $0.50 dividend.
Thu Oct 9, 2025
Why Zoetis (ZTS) Remains a Reliable Choice for Investors Seeking Profitable Dividend Stocks. Zoetis Inc. (NYSE:ZTS) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now. Zoetis Inc. (NYSE:ZTS) offers a range of drugs and healthcare products for companion animals and livestock worldwide. The company keeps innovating with a portfolio that includes seven main product categories and about 300 product lines. As younger generations show [….]
Wed Oct 8, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.